Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $43.6 billion.

  • Bristol Myers Squibb's Treasury Shares fell 17.41% to $43.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $43.6 billion, marking a year-over-year decrease of 17.41%. This contributed to the annual value of $43.6 billion for FY2025, which is 17.41% down from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Treasury Shares is $887.0 million, which was down 78.3% from $887.0 million recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Treasury Shares ranged from a high of $902.0 million in Q4 2023 and a low of $7.0 million during Q3 2021
  • For the 5-year period, Bristol Myers Squibb's Treasury Shares averaged around $729.3 million, with its median value being $860.5 million (2023).
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 2936.87% in 2022, then fell by 25.36% in 2024.
  • Bristol Myers Squibb's Treasury Shares (Quarter) stood at $31.3 billion in 2021, then rose by 23.54% to $38.6 billion in 2022, then rose by 13.33% to $43.8 billion in 2023, then decreased by 0.25% to $43.7 billion in 2024, then fell by 0.17% to $43.6 billion in 2025.
  • Its last three reported values are $43.6 billion in Q4 2025, $43.6 billion for Q3 2025, and $43.6 billion during Q2 2025.